908 Devices Inc. (MASS) stock
MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3028% above fair value
$9.74−0.05 (-0.51%)
Close on Nov 13, 2026Market cap $402.59MP/E –Yield –
908 Devices cash
Cash and short-term investments held at the end of each period.
908 Devices's cash was $99.12M at Sep 30, 2026. For fiscal 2025 it was $112.97M, up 61.9% from the year before. The highest annual figure on record is $224.13M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.97M | +61.9% |
| FY2024 | Dec 31, 2024 | $69.77M | -52.2% |
| FY2023 | Dec 31, 2023 | $145.85M | -22.7% |
| FY2022 | Dec 31, 2022 | $188.59M | -15.9% |
| FY2021 | Dec 31, 2021 | $224.13M | +40.8% |
| FY2020 | Dec 31, 2020 | $159.23M | +788.9% |
| FY2019 | Dec 31, 2019 | $17.91M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $99.12M | -11.5% |
| Q2 FY2026 | Jun 30, 2026 | $101.53M | -14.4% |
| Q1 FY2026 | Mar 31, 2026 | $111.74M | -10.1% |
| Q4 FY2025 | Dec 31, 2025 | $112.97M | +61.9% |
| Q3 FY2025 | Sep 30, 2025 | $112.05M | +56.3% |
| Q2 FY2025 | Jun 30, 2025 | $118.58M | +53.2% |
| Q1 FY2025 | Mar 31, 2025 | $124.32M | -7.4% |
| Q4 FY2024 | Dec 31, 2024 | $69.77M | -52.2% |
| Q3 FY2024 | Sep 30, 2024 | $71.69M | -51.5% |
| Q2 FY2024 | Jun 30, 2024 | $77.38M | -49.3% |
| Q1 FY2024 | Mar 31, 2024 | $134.20M | -16.8% |
| Q4 FY2023 | Dec 31, 2023 | $145.85M | -22.7% |
| Q3 FY2023 | Sep 30, 2023 | $147.90M | -23.6% |
| Q2 FY2023 | Jun 30, 2023 | $152.69M | -28.3% |
| Q1 FY2023 | Mar 31, 2023 | $161.21M | -27.7% |
| Q4 FY2022 | Dec 31, 2022 | $188.59M | -15.9% |
| Q3 FY2022 | Sep 30, 2022 | $193.70M | +39.5% |
| Q2 FY2022 | Jun 30, 2022 | $212.99M | +50.7% |
| Q1 FY2022 | Mar 31, 2022 | $223.12M | +49.8% |
| Q4 FY2021 | Dec 31, 2021 | $224.13M | +40.8% |
| Q3 FY2021 | Sep 30, 2021 | $138.82M | +604.2% |
| Q2 FY2021 | Jun 30, 2021 | $141.31M | +1146.7% |
| Q1 FY2021 | Mar 31, 2021 | $148.96M | +916.3% |
| Q4 FY2020 | Dec 31, 2020 | $159.23M | +788.9% |
| Q3 FY2020 | Sep 30, 2020 | $19.71M | – |
| Q2 FY2020 | Jun 30, 2020 | $11.34M | – |
| Q1 FY2020 | Mar 31, 2020 | $14.66M | – |
| Q4 FY2019 | Dec 31, 2019 | $17.91M | – |
See a number that looks wrong?